Aztec Protocol enables private transactions on Ethereum. It uses a zero-knowledge proof system, allowing users to effectively create shielded representations of tokens, which can then be sent and redeemed for the underlying token. They recently launched Aztec 2.0 and their rollup service for Ethereum, zk.money. This allows users to submit Ether to the Aztec rollup contract with the options to shield, send privately, unshield and emergency ushield (escape hatch). The latest version also allows DeFi users to save gas and participate anonymously in DeFi transactions. We were joined by Zac Williamson, Co-founder and CTO, and Joe Andrews, Head of Product, from Aztec, to give us an in-depth look into the Layer 2 project and explain how version 2 of the protocol in a game-changer in terms of privacy and scalability. Topics covered in this episode: What has happened in the last year since Aztec were last on the showHigh-level overview of AztecHow the Aztec rollup works in DeFi applicationsThe challenges privacy introduces for DeFiSNARK, the core technology that powers AztecNoir (zkSNARK DSL)Episode links: Episode 335 - Aztec Protocol – Bringing Zero-Knowledge Transactions to Ethereumzk.moneyDiscordAztec on TwitterJoe on TwitterZac on TwitterSponsors: ParaSwap: ParaSwap aggregates all major DEXs and makes sure you beat the market price at every single swap and with the lowest slippage - http://paraswap.io/epicenter - paraswap.io/epicenterChorus One: Chorus One runs validators on cutting edge Proof of Stake networks such as Cosmos, Solana, Celo, Polkadot and Oasis. - https://epicenter.rocks/chorusoneThis episode is hosted by Sebastien Couture & Dev Ojha. Show notes and listening options: epicenter.tv/405

VitaDAO is a decentralized collective funding early stage longevity research. Their mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner. We were joined by Tyler Golato and Paul Kohlhaas, co-founders of Molecule and initiators of VitaDAO to talk about how drug discovery and approval currently works, what the status of longevity research is, what role IP plays -- and how all of this could change in the future with DAOs like VitaDAO. Topics covered in this episode: Paul and Tyler's backgrounds and how they came to work on VitaDAOLongevity - thinking of aging as a diseaseWhere is the research at today?How longevity research currently takes place in the pharmaceutical industryHow VitaDAO is alleviating patency issuesThe first funded project with the Knudsen lab in Copenhagen - MoleculeHow DAOs make the decisionsEpisode links: The Molecule blogVitaDAOGoldman asks: 'Is curing patients a sustainable business model?'VitaDAO DiscordVitaDAO on TwitterMolecule on TwitterPaul on TwitterTyler on TwitterSponsors: Chorus One: Chorus One runs validators on cutting edge Proof of Stake networks such as Cosmos, Solana, Celo, Polkadot and Oasis. - https://epicenter.rocks/chorusoneParaSwap: ParaSwap aggregates all major DEXs and makes sure you beat the market price at every single swap and with the lowest slippage - http://paraswap.io/epicenter - paraswap.io/epicenterThis episode is hosted by Friederike Ernst & Meher Roy. Show notes and listening options: epicenter.tv/403